The World Professional Association of Transgender Health (WPATH), the organization whose medical guidance informs clinical practice, insurance policy, and government regulations throughout the United States, faced renewed scrutiny this week after internal forum messages showed its members discussing the need for formalized protocols to treat patients seeking to reverse gender-transition procedures. The messages, obtained through a public records request by The Daily Wire, were written between June 2024 and November 2024 in WPATH's member-only online forum.
The Federal Trade Commission filed a lawsuit against WPATH in June 2026, alleging the organization has "misled parents and children about the medical consensus and medical necessity, as well as the safety and effectiveness" of child sex-change interventions. The FTC lawsuit is ongoing and has not been resolved by a court.
In one forum thread titled "De-transition Protocols/Policies," Dr. Christopher Terndrup, associate director of the LGBTQ+ Healthcare Fellowship Program at Vanderbilt Health, asked for guidance on treating patients wanting to return to their original sex after undergoing procedures such as vaginoplasty, breast augmentation, double mastectomy, hysterectomy, and oophorectomy.
What the Right Is Saying
Critics, including Dr. Kurt Miceli, chief medical officer at Do No Harm, a healthcare advocacy organization, say the internal messages expose what he called "a fundamental inconsistency" in WPATH's public positions.
"There is a critical and undeniable need for detransitioner protocols—a reality acknowledged even by WPATH's own members," Miceli told The Daily Wire. "Yet this is the same organization that has ignored systematic review upon systematic review as it promotes harmful and irreversible sex-rejecting procedures for minors."
Conservative critics point to SOC-8's recommendation that children have access to irreversible sex-change surgeries without any age minimums, arguing this contradicts WPATH's claim in its public guidance that detransition is "proportionally rare" while simultaneously not providing formal protocols for those patients. They argue the FTC lawsuit validates concerns about whether WPATH has adequately communicated risks to patients and families.
What the Left Is Saying
Advocates for gender-affirming care say the internal forum discussions demonstrate that medical professionals are engaged in ongoing efforts to develop comprehensive care standards rather than dismissing patients who detransition. They note that WPATH's Standards of Care Version 8 (SOC-8) already acknowledges providers should be prepared to support adolescents who detransition.
Psychologists quoted in the forum messages emphasized the importance of offering patients what one described as "a non-regret focused frame — ie, that they are embracing who they are at this moment and taking positive steps to embody themselves." Another member wrote, "I still think that we should be developing protocols to handle this regardless of how many detransitioners there are. I think it's important."
LGBTQ+ healthcare advocates argue that the existence of these forum discussions reflects responsible medical practice—clinicians identifying gaps in care and seeking to address them through peer consultation rather than ignoring patients with complex needs.
What the Numbers Show
WPATH's SOC-8, which serves as a foundational document for transgender medical care in the United States, recommends that children have access to irreversible sex-change surgeries without any specified age minimums. The organization publicly characterizes detransition as "proportionally rare" while acknowledging healthcare providers should support adolescents who detransition—a position it maintains without providing formal clinical protocols.
The FTC lawsuit, filed June 2026, remains pending. The Daily Wire obtained approximately 250 pages of WPATH forum messages through public records requests spanning June through November 2024. Dr. Christopher Terndrup's message seeking de-transition protocol guidance was part of a thread in which multiple members acknowledged the absence of standardized medical pathways for patients reversing gender-affirming procedures.
Vanderbilt Health has not commented publicly on Dr. Terndrup's forum participation as a private WPATH member.
The Bottom Line
The internal messages add new dimensions to an already contentious debate over pediatric gender medicine. WPATH, which sets standards that influence insurance coverage and clinical practice nationwide, now faces FTC allegations that it misled consumers about medical interventions for minors while simultaneously being shown discussing internally the absence of care protocols for those who seek to reverse those same interventions.
The FTC lawsuit is scheduled for court proceedings in 2027. Medical professionals on all sides of this issue have called for more rigorous longitudinal research on patient outcomes, including rates and experiences of detransition. What remains clear from both internal discussions and public positions is that clinicians recognize the medical complexity involved in caring for patients who reverse gender-affirming procedures—a recognition that critics say should have been more prominently featured in informed consent materials provided to families.